Benjamin Hohl
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 3,53540,483 held (−8%) | $50.03 | $177K | -18.1% |
| Sep 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 2,19438,289 held (−5%) | $50.72 | $111K | -19.2% |
| Sep 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 28938,000 held (−1%) | $51.49 | $15K | -20.4% |
| Aug 19SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 4,63041,424 held (−10%) | $58.35 | $270K | -29.8% |
| Aug 19SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 1,38840,036 held (−3%) | $59.35 | $82K | -31.0% |
| Jul 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 32451,748 held (−1%) | $49.97 | $16K | -18.0% |
| Jul 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 36951,379 held (−1%) | $51.48 | $19K | -20.4% |
| Jul 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 2,56448,815 held (−5%) | $52.32 | $134K | -21.7% |
| Jul 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 2,63846,177 held (−5%) | $53.38 | $141K | -23.2% |
| Jul 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 12346,054 held (−0%) | $53.87 | $7K | -23.9% |
| Jun 22SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 1,37955,639 held (−2%) | $42.79 | $59K | -4.2% |
| Jun 22SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 3,40152,238 held (−6%) | $43.86 | $149K | -6.6% |
| Jun 22SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 1,23851,000 held (−2%) | $44.75 | $55K | -8.4% |
| Mar 10SEC | ELVNEnliven Therapeutics, Inc. | Sell | 10,00051,000 held (−16%) | $29.58 | $296K | +38.5% |
| Oct 1SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 3,25023,000 held (−12%) | $20.40 | $66K | +100.9% |
- Sell
CFO Benjamin Hohl sold $177K of ELVN at $50.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Benjamin Hohl sold $111K of ELVN at $50.72 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Benjamin Hohl sold $15K of ELVN at $51.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Benjamin Hohl sold $270K of ELVN at $58.35 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Benjamin Hohl sold $82K of ELVN at $59.35 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Benjamin Hohl sold $16K of ELVN at $49.97 — pre-scheduled 10b5-1 plan sale.